We are investigating Arsanis, Inc. (NasdaqGM: ASNS) regarding its acquisition of X4 Pharmaceuticals, Inc. (“X4”) for 0.5948 shares of Arsanis common stock for each share of X4.
We are investigating Arsanis, Inc. (NasdaqGM: ASNS) regarding its acquisition of X4 Pharmaceuticals, Inc. (“X4”) for 0.5948 shares of Arsanis common stock for each share of X4.